Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Where is the brokerage coverage to defend the stock? They are going to need cash at some point..
The ugliest thing is the competition and their proxies are rallying around stopping RVNC’s progress. If the injectors avoid stocking Daxxi, that is not good.
Therapeutics might be the only way out of this mess.
This is a good review after 9 months
Could they sell the company today for $8? Asking for a colleague..
Well stated…
Funny, I remember posters saying the same thing when Dan Browne was running the show……
I don’t think so………
Apple-oranges…
Mr. Wilson has spent too much effort discussing this compound with Dennis.. (aka, Dennis the Menace)
Wow. They are quite creative:
https://stocktwits.com/making_money81/message/566937952
$17.63. Heading to $20
I think you might be right..
Looks like a concerted effort
That is what I thought, but some poster here stated middle of 2025. I should have caught their erroneous statement.
Really surprising that this is here now:
https://stocktwits.com/Big_Red2/message/566327711
“Therapeutics won't really kick off until mid '25, and upside might be limited due to lowest dose being very effective and them giving 20% discount on this dose due to repricing.”
They will achieve some market value before that. There is some sizzle hiding for the therapeutic use for this innovative compound.
I’m just surprised the therapeutic approval didn’t provide any support for this stock. The share price went right through it.
I didn’t invest in this again for the cosmetic application, too competitive.
Since this has dropped below $5, anything is possible now..
This is acting as if it wants to be a footnote in history……
Well, with that answer, I change my assumption to desperation…..😁
This should be shut down by now..
Zzaatt sounds nervous…
Oh my God! What happened???
Did a patient die?? Did they discover an unknown toxicity?? Is the company running out of money?? NOPE! None of the above. We missed "estimates" by a few pennies. My feeling is the "estimators" had no clue and the company will continue to chug along and as it start showing a profit, either the PPS will go up, or there will be buyout. Not to worry.
They DEFINITELY needed to. I’m thinking they needed to get ahead of the next quarter results as they don’t have a clue what the uptake will be..
Doubt management bought into this.
$13.56
I would classify as a RVNC hit piece just posted on Seeking Alpha. They are after RVNC…
I propose it is time to re-enter after my five year absence.
Post on 8/14/23:
DeNovo submitted to the FDA finally.
What happened??
Chugging along is an appropriate descriptor…
Well, at least they provided an honest, non sugar coated report on the offers.
Clyde Crash Cop comes to mind..
Scary! A third of patient with lupus nephritis who are considered complete respondues continue to aaccrue progressive renal damage - @Andreafava @rheumnow #RNL2024 pic.twitter.com/mhu3YoY3YV
— TheDaoIndex (@KDAO2011) January 27, 2024
Wow, that is a must watch.! Thank you..
Yes, it looks like it wants $5. This has to be raising flags somewhere..
Ye-ha, we got to the new year, so I could sell most all my shares. Thank you KR!
Stinky..
you awoke the beast! -True